Dr. Lal Path Labs Ltd. — Board Meeting, 30-01-2026: Outcome of Board Meeting
30-01-2026 | 01:23 pm
30-01-2026 | 01:23 pm
Dr. Lal PathLabs' Board approved consolidated financial results for the quarter and nine months ended Dec 31, 2025. Revenue hit ₹659.8 Cr, with profit at ₹91.4 Cr. A ₹3.5/share interim dividend was declared. Additionally, 4,000 ESOP shares were allotted.
No comments yet. Be the first to comment!
